|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pediatrics/Nephrology, Tulane University School of Medicine, New Orleans, LA, USA
* To whom correspondence should be addressed. E-mail: seldahr{at}tulane.edu.
Gene-environment interactions are implicated in congenital human disorders. Accordingly, there is a pressing need to develop animal models of human disease, which are the product of defined gene-environment interactions. Previously, we demonstrated that gestational salt stress of
bradykinin B2-receptor (B2R)-null mice induces renal dysgenesis and early death of the offspring. In contrast, salt-stressed B2R+/+ or +/- littermates have normal development. The present study investigates the mechanisms underlying the susceptibility of B2R-null mice to renal dysgenesis. Proteomic and conventional Western blot screens identified E-cadherin among the differentially
repressed proteins in B2R-/- kidneys, whereas the checkpoint kinase, Chk1, and its substrate, P-Ser20 p53, were induced. We tested the hypothesis that p53 mediates repression of E-cadherin gene expression and is causally linked to the renal dysgenesis. Genetic crosses between B2R-/- and p53+/- mice revealed that germline reduction of p53 gene dosage rescues B2R-/- mice from renal dysgenesis and restores kidney E-cadherin gene expression. Furthermore,
-irradiation
induces repression of E-cadherin gene expression in p53+/+ but not -/- cells. In transient transfection assays, p53 repressed human E-cadherin promoter-driven reporter activity, whereas a mutant p53, which cannot bind DNA, did not. Functional promoter analysis indicated the presence of a p53-responsive element in exon 1, which partially mediates p53-induced repression. Chromatin immunoprecipitation assays revealed that p53 inhibits histone acetylation of the E-cadherin promoter. Treatment with a histone deacetylase inhibitor reversed both
p53-mediated promoter repression and deacetylation. In conclusion, this study demonstrates that gene-environment interactions cooperate to induce congenital defects through p53 activation.
This article has been cited by other articles:
![]() |
H. Fan, J. Stefkova, and S. S. El-Dahr Susceptibility to metanephric apoptosis in bradykinin B2 receptor null mice via the p53-Bax pathway Am J Physiol Renal Physiol, September 1, 2006; 291(3): F670 - F682. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zamorano, S. Suchindran, and J. V. Gainer 3'-Untranslated region of the type 2 bradykinin receptor is a potent regulator of gene expression Am J Physiol Renal Physiol, February 1, 2006; 290(2): F456 - F464. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Bates Transcriptional control of renal collecting duct development Am J Physiol Renal Physiol, May 1, 2005; 288(5): F897 - F898. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |